Alzinova AB (publ) (Nasdaq First North: ALZ) today announced that the company has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for the planned P ...

British drugmaker GSK said on Monday its supplemental new drug application for antibiotic drug gepotidacin has been accepted for priority review by the U.S. Food and Drug Administration for the oral ...

Last independent King’s Road shoe shop could shut as Raffles Chelsea eyes basement for expansion - Hassan Salimian says ...

US FDA announces new FDA PreCheck programme to boost US drug manufacturing: Silver Spring, Maryland Saturday, August 9, 2025, 12:00 Hrs [IST] The US Food and Drug Administration a ...

FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatmentSignifi ...

According to the PCs, Winnipeg Fire Paramedic Service data shows a 25% decline in overdose-related calls and a 29% decrease in naloxone use since the organization’s previous drug injection RV was ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

A new two-phase initiative aims to streamline facility approvals, reduce reliance on foreign pharmaceutical production, and ...

It’s meant to intimidate,” said Bill Ong Hing of the Immigration and Deportation Defense Clinic. "They will try to withhold ...

Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or ...

R&D expense was $11.7 million for the three months ended June 30, 2025, compared to $7.6 million for the same period in 2024. The increase was primarily driven by higher research, development, ...

Pipeline Regulatory Progress -- Two risk-adjusted product launches (AMP-002 and AMP-015) are included in the flat full-year ...